Filing Details

Accession Number:
0001062993-15-003350
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-12 16:10:07
Reporting Period:
2015-06-10
Filing Date:
2015-06-12
Accepted Time:
2015-06-12 16:10:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1314052 Anavex Life Sciences Corp. AVXL Services-Commercial Physical & Biological Research (8731) 208365999
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1196573 U Christopher Missling 51 W 52Nd Street, 7Th Floor
New York NY 10019-6163
President,Ceo,Cfo & Treasurer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-10 1,000 $0.36 3,003,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchases reported in this Form 4 were effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on June 3, 2015.
  2. Includes 2,000,000 stock options that have vested and 1,000,000 shares of restricted common stock that have vested pursuant to the achievement of certain objectives. Does not include 3,000,000 shares of restricted common stock that vest pursuant to the achievement of certain objectives.